Dopamine- and serotonin-related grey matter atrophy in patients with Alzheimer’s disease and psychosis
Year: 2026
Type: article
Abstract: Polygenic risk scores for schizophrenia (SCZ-PRS) may represent risk factors for psychotic symptoms in Alzheimer’s disease (AD). Since dopamine (DA) and serotonin (5HT) have been implicated in psychosis, this study investigated grey matter volume (GMV) loss associated with atlas-derived DA and 5HT distribution in AD-related psychosis and the relationship with a SCZ-PRS. Data of 98 patients with AD and psychosis (PT-PS) and 308 without psychosis (PT-NP), all amyloid-positive, were selected from the Alzheimer’s Diseases Neuroimaging Initiative. T1-weighted MRI scans were pre-processed with JuSpace to quantify the association between regional GMV and atlas-derived DA/5HT distributions. Generalised linear models were used to test the association between a SCZ-PRS and neurotransmitter-GMV correlation coefficients. PT-PS patients had smaller GMV than PT-NP in areas where 5HT1b receptor distribution is lower and D2 receptor and DA transporter distribution are higher. GMV alterations were primarily in medio-temporal areas, but the SCZ-PRS was not associated with GMV-neurotransmitter correlations. Although this study assessed neurotransmitter dysfunction indirectly via atlas-based estimates and findings are correlational, they offer insights complementary to previous evidence on the neurobiological underpinning of AD-related psychosis. Further investigations are needed to replicate these findings and to test the mechanistic involvement of neurotransmitters in AD-related psychosis.
Source: Scientific Reports
Institutions: University of Parma, Cardiff University, University of Sheffield
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7225871787
